A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.

Summary

The purpose of this randomized, controlled, multicenter study is to evaluate the safety and efficacy of TTAX03 in participants with mild to moderate DED. The primary question it aims to answer is if TTAX03 is safe. The secondary is the effectiveness. Researchers will compare 10mg of TTAX03 reconstituted in 150, 300, or 600 uL saline to the saline control group to look at effectiveness. Participants will be randomized to a treatment group one time and be evaluated at 5 different study visits.

Timeline

Start

2024-12-12

Primary completion

2026-01-30

Completion

2026-01-30

Drugs

Indications